Up a level |
Ramanan, Athimalaipet V, Dick, Andrew D, Jones, Ashley P, Hughes, Dyfrig A ORCID: 0000-0001-8247-7459, McKay, Andrew ORCID: 0000-0003-1312-8911, Rosala-Halas, Anna, Williamson, Paul R ORCID: 0000-0001-9802-6636, Hardwick, Ben, Hickey, Helen ORCID: 0000-0003-0467-0362, Rainford, Naomi ORCID: 0000-0002-5876-3946 et al (show 10 more authors)
(2019)
Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
HEALTH TECHNOLOGY ASSESSMENT, 23 (15).
pp. 1-139.
Ghaneh, Paula, Hanson, Robert, Titman, Andrew, Lancaster, Gill, Plumpton, Catrin, Lloyd-Williams, Huw, Yeo, Seow Tien, Edwards, Rhiannon Tudor, Johnson, Colin, Abu Hilal, Mohammed et al (show 30 more authors)
(2018)
PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality <SUP>18</SUP>fluorine-2-fluoro-2-deoxy-D-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer.
HEALTH TECHNOLOGY ASSESSMENT, 22 (7).
1-+.
Holmes, Emily AF, Plumpton, Catrin, Baker, Gus A, Jacoby, Ann, Ring, Adele, Williamson, Paula ORCID: 0000-0001-9802-6636, Marson, Anthony ORCID: 0000-0002-6861-8806 and Hughes, Dyfrig A ORCID: 0000-0001-8247-7459
(2019)
Patient-Focused Drug Development Methods for Benefit-Risk Assessments: A Case Study Using a Discrete Choice Experiment for Antiepileptic Drugs.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 105 (3).
pp. 672-683.
Hagemi, Anke, Plumpton, Catrin and Hughes, Dyfrig A ORCID: 0000-0001-8247-7459
(2017)
Renal transplant patients' preference for the supply and delivery of immunosuppressants in Wales: a discrete choice experiment.
BMC NEPHROLOGY, 18 (1).
305-.
Marson, Anthony ORCID: 0000-0002-6861-8806, Burnside, Girvan ORCID: 0000-0001-7398-1346, Appleton, Richard, Smith, Dave, Leach, John Paul, Sills, Graeme, Tudur-Smith, Catrin ORCID: 0000-0003-3051-1445, Plumpton, Catrin, Hughes, Dyfrig A ORCID: 0000-0001-8247-7459, Williamson, Paula ORCID: 0000-0001-9802-6636 et al (show 9 more authors)
(2021)
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
LANCET, 397 (10282).
pp. 1363-1374.
Marson, Anthony ORCID: 0000-0002-6861-8806, Burnside, Girvan ORCID: 0000-0001-7398-1346, Appleton, Richard, Smith, Dave, Leach, John Paul, Sills, Graeme, Tudur-Smith, Catrin ORCID: 0000-0003-3051-1445, Plumpton, Catrin, Hughes, Dyfrig A ORCID: 0000-0001-8247-7459, Williamson, Paula ORCID: 0000-0001-9802-6636 et al (show 9 more authors)
(2021)
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
LANCET, 397 (10282).
pp. 1375-1386.
Balabanova, Silviya ORCID: 0000-0001-6989-8099, Taylor, Claire, Sills, Graeme, Burnside, Girvan ORCID: 0000-0001-7398-1346, Plumpton, Catrin, Smith, Phil EM, Appleton, Richard, Leach, John Paul, Johnson, Michael, Baker, Gus et al (show 5 more authors)
(2020)
Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of standard and new antiepileptic drugs (SANAD-II).
BMJ open, 10 (8).
e040635-e040635.
Farmer, Andrew, Jones, Louise, Newhouse, Nikki, Kenning, Cassandra, Williams, Nicola, Chi, Yuan, Bartlett, Y Kiera, Plumpton, Catrin, McSharry, Jenny, Cholerton, Rachel et al (show 15 more authors)
(2022)
Supporting People With Type 2 Diabetes in the Effective Use of Their Medicine Through Mobile Health Technology Integrated With Clinical Care to Reduce Cardiovascular Risk: Protocol for an Effectiveness and Cost-effectiveness Randomized Controlled Trial.
JMIR research protocols, 11 (2).
e32918-e32918.